While previous trials have led to questions surrounding the potential benefits of valve interventions in mitral or tricuspid regurgitation, a pair of trials presented recently demonstrate their ...
The RESHAPE-HF2 trial aimed to settle the debate initiated by the conflicting COAPT and MITRA-FR trials, however, it did not clarify the role of transcatheter edge-to-edge repair in heart failure.
Narayana Health sets its first-of-its-kind robotic cardiac centre of excellence: Our Bureau, Bengaluru Wednesday, September 25, 2024, 17:40 Hrs [IST] Narayana Health, unveiled fir ...
Cardia Ltd., a global leader in the development of leaflet modification solutions for treating heart valves, announced today that the United States Food and Drug Administration (FDA) provided market ...